Catapult Pharmacology
Neurokinin-1 Receptor Blockers
Aprepitant is a neurokinin-1 receptor blocker. Aprepitant is indicated in the treatment of chemotherapy induced nausea and vomiting as well as postoperative nausea and vomiting. Aprepitant works by blocking the effects of substance P, which is released in response to chemotherapy and stimulates chemoreceptors in the brainstem, by blocking the neurokinin-1 receptor. Aprepitant is metabolized by CYP450 system, so it affects metabolism of other medications such as warfarin.
Class Drugs
- Aprepitant
Class Mechanism of Action
Central neurokinin receptor blocker
Class Applications
Chemotherapy induced nausea
Postoperative nausea and vomiting
Class Adverse Effects
Metabolized by CYP3A4 (Affects metabolism of other drugs such as warfarin)
Drug Table
| Drug Name | Application | Comments | Image |
|---|---|---|---|
| Aprepitant | "Prep Book" "Ant" |